Kalvista Pharmaceuticals Inc. (KALV)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 1,928,200 $18,973 +11% 0.72%
2. 1,824,000 $17,948 +6% 1.17%
3. 1,800,000 $17,712 +178% 2.68%
4.
Vivo Capital

Albert Cha And Frank Kung

1,533,559 $15,090 1.51%
5.
Great Point Partners

Jeffrey Jay And David Kroin

1,530,000 $15,055 +76% 3.61%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.34 47,431 Director 1,138,179 2020-10-30 Filing
$17.17 68,255 Director 1,090,748 2020-10-30 Filing
$11.87 7,962 Director 10,000 2019-09-27 Filing
$11.90 2,038 Director 2,038 2019-09-26 Filing
$17.13 5,137 Director 124,566 2019-07-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.01 1,320 Officer, Director 110,858 2022-09-02 Filing
$14.96 725 Officer 1,693 2022-08-17 Filing
$14.96 532 Officer 61,132 2022-08-17 Filing
$14.96 1,145 Officer 33,597 2022-08-17 Filing
$14.96 725 Officer 66,693 2022-08-17 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,760 $383,233 3.99%
2. 5,958 $58,627 0%
3. 1,671,495 $16,448 0%
4. 1,572,192 $15,470 1.45%
5. 1,157,158 $11,386 0%
News See All